Articles related to CARDIOVASCULAR DISEASE (CVD)
The Dangers of ‘Bikini Medicine’
‘Bikini medicine’ (see the Boston Globe article) is an outdated, sexist idea that men and women should be cared for similarly — dubbed as such due to the mistaken belief that women’s health only differs in the parts of women that bikinis cover. A ridiculous notion, considering that cardiovascular disease, osteoporosis, and autoimmune diseases affect women differently than men. Last time we checked, the bikini doesn’t cover any of them.
Cardiology July 13th 2022
Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement
In this update to its 2014 recommendation, the USPSTF concluded “with moderate certainty that the harms of beta carotene supplementation outweigh the benefits for the prevention of cardiovascular disease or cancer.”
Cardiology June 29th 2022
Physicians Debate Statin Use for Patients with Cardiovascular Disease
In a look “Beyond the Guidelines,” a preventive cardiologist and a general internist discuss their approach in the case of a 57-year-old woman with high cholesterol and a family history of heart disease.
Cardiology June 23rd 2022
Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption with All-Cause and Cause-Specific Mortality
In a 7-year study of 171,000 individuals with a mean age of 56 years, these researchers elucidate the hazard ratio for death from CVD or cancer and levels of daily coffee consumption.
Cardiology June 7th 2022
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes (T2D) w. Sodium–Glucose Cotransporter-2 Inhibitors (SGLT-2i) vs. Metformin
A new study published in Annals of Internal Medicine looks at the link between cardiovascular disease among adults with type 2 diabetes, which might be more prevalent than previously thought. This study compares cardiovascular outcomes in patients taking first line metformin vs. SGLT-2 inhibitors, based on claims data over a 7-year period. SGLT-2 inhibitor use was associated with lower rates of hospitalization for heart failure and all cause mortality. Rates for MI and stroke were similar for the two treatments.
Cardiology May 31st 2022
Clinical Challenges: Cardiac Conditions of COVID Long-Haulers: Do COVID survivors with cardiac conditions need special treatment and monitoring?
A report in MedPage Today states that standard heart care is recommended for COVID-19 survivors left with cardiomyopathy and other cardiac conditions, though more answers are needed regarding how long they need to undergo special monitoring, and which groups are at particularly high risk.
Cardiology May 17th 2022